WOODHOUSE DAVID J

CIK 00016429952 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001642995

Recent Transactions

47 trades

Award
Surrozen, Inc./DE$SRZN
Option (right to buy)
2025-05-14+1,333→ 1,333 total
Award
Surrozen, Inc./DE$SRZN
Option (right to buy)
2024-06-05+1,333→ 1,333 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−450,000→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−87,013→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−255,000→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−200,000→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−500,000→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−381,600→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−400,000→ 0 total
Disposition from Tender
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−23,993→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−500,000→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−57,833→ 0 total
Disposition from Tender
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−97,654→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Restricted Stock Unit
2024-04-05−95,400→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−500,000→ 0 total
Tax Payment
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-01-16$1.34/sh−13,032→ 131,822 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06−255,000→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06−57,833→ 0 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06+200,000→ 200,000 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06+57,833→ 57,833 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06−500,000→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06−200,000→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06−400,000→ 0 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06+400,000→ 400,000 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06−450,000→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06−500,000→ 0 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06+87,013→ 87,013 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06+450,000→ 450,000 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06+500,000→ 500,000 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06+255,000→ 255,000 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06−87,013→ 0 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-11-06+500,000→ 500,000 total
Award
Surrozen, Inc./DE$SRZN
Option (right to buy)
2023-05-18+20,000→ 20,000 total
Award
NGM BIOPHARMACEUTICALS INC
Common Stock
2023-03-02+127,200→ 144,854 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-03-02+381,600→ 381,600 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-03-02+500,000→ 500,000 total
Award
Surrozen, Inc./DE$SRZN
Option (right to buy)
2022-06-07+20,000→ 20,000 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2022-03-03+500,000→ 500,000 total
Exercise/Conversion
NGM BIOPHARMACEUTICALS INC
Common Stock
2021-12-29$8.14/sh+4,667→ 17,654 total
Exercise/Conversion
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-12-29−4,667→ 57,833 total
Exercise/Conversion
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-12-29−12,987→ 87,013 total
Exercise/Conversion
NGM BIOPHARMACEUTICALS INC
Common Stock
2021-12-29$7.70/sh+12,987→ 12,987 total
Exercise/Conversion
NGM BIOPHARMACEUTICALS INC
Common Stock
2021-11-18$7.54/sh+15,000→ 15,000 total
Sale
NGM BIOPHARMACEUTICALS INC
Common Stock
2021-11-18$20.02/sh−15,000→ 0 total
Exercise/Conversion
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-11-18−15,000→ 255,000 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-03-17+450,000→ 450,000 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2020-02-04+400,000→ 400,000 total

Companies

Recent Filings

Address

C/O SURROZEN, INC. 171 OYSTER POINT BLVD., SUITE 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov